Related Experiment Videos
T-cell adoptive immunotherapy: moving ahead by going in a circle
1Vion Pharmaceuticals, New Haven, Connecticut 06511, USA.
Cancer Journal (Sudbury, Mass.)
|November 9, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.
The cancer journal from Scientific American·2000
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
The Quest to Cure Metastatic Non-Small Cell Lung Cancer With Immunotherapy.
Cancer journal (Sudbury, Mass.)·2026
KRAS-mutated Non-Small Cell Lung Cancer: Drugging the Undruggable.
Cancer journal (Sudbury, Mass.)·2026
Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.
Cancer journal (Sudbury, Mass.)·2026
Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.
Cancer journal (Sudbury, Mass.)·2026
Management of Classic Hodgkin Lymphoma in Special Clinical Situations.
Cancer journal (Sudbury, Mass.)·2026